CASTLE BIOSCIENCES, INC. Payments to Acquire Finance Receivables
CASTLE BIOSCIENCES, INC. (CSTL) reported Payments to Acquire Finance Receivables of $2.11 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireFinanceReceivables · last filed 2026-02-26
- CASTLE BIOSCIENCES, INC. payments to acquire finance receivables for fiscal 2025 was $2.11M.
- CASTLE BIOSCIENCES, INC. payments to acquire finance receivables for fiscal 2024 was $0.00.
- CASTLE BIOSCIENCES, INC. payments to acquire finance receivables for fiscal 2023 was $0.00.
| Period end | Payments to Acquire Finance Receivables 12 month |
|---|---|
| 2025-12-31 | $2.11M 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |